Archives
PFOS Triggers Ferroptosis and ER Stress in Human Renal Cells
2026-05-25
PFOS Triggers Ferroptosis and ER Stress in Human Renal Cells
Study Background and Research Question
Perfluorooctane sulfonate (PFOS) is a synthetic perfluorinated compound noted for its exceptional chemical stability and widespread use in industrial applications such as chemical plating, non-stick cookware, and textile manufacturing. Due to its resistance to degradation and ability to bioaccumulate, PFOS is now recognized as an environmental contaminant of concern, with detectable levels in human tissues and water sources worldwide. The kidney, being the primary organ responsible for PFOS excretion, is particularly vulnerable to its toxic effects. Previous studies demonstrated that PFOS exposure is linked to renal hypertrophy, microangiopathy, and tissue proliferation in animal models, but the cellular mechanisms underlying PFOS-induced kidney injury in humans remained poorly defined. The key research question addressed in the reference study is: How does PFOS exposure injure human proximal tubular epithelial (HK-2) cells, and what are the molecular pathways involved?Key Innovation from the Reference Study
This investigation is among the first to demonstrate, with direct experimental evidence, that PFOS can induce cell injury through the combined activation of ferroptosis and endoplasmic reticulum (ER) stress pathways in human renal cells. While prior research had linked PFOS to general cytotoxicity and organ damage, this study delineates the specific programmed cell death mechanisms—namely, ferroptosis, an iron-dependent form of non-apoptotic cell death, and ER stress, which disrupts protein folding and cellular homeostasis. The dual-pathway insight is critical for developing targeted therapeutic or preventive strategies against PFOS-induced renal toxicity.Methods and Experimental Design Insights
The authors utilized HK-2 cells, a well-established model of human proximal tubular epithelium, and exposed them to 200 μM PFOS for defined periods. They assessed cell viability, markers of oxidative stress, and iron metabolism, as well as expression levels of proteins associated with ferroptosis and ER stress. Key methodological highlights include:- Ferroptosis assessment: Measurement of malondialdehyde (MDA), glutathione (GSH), intracellular iron, and glutathione peroxidase 4 (GPX-4) to evaluate lipid peroxidation, redox status, and iron-dependent cell death.
- Renal injury biomarkers: Evaluation of kidney injury molecule-1 (KIM-1) as an indicator of tubular damage.
- ER stress and unfolded protein response (UPR): Quantification of GRP78, ATF6, IRE1, and PERK protein levels to characterize ER stress pathway engagement.
- Pharmacological modulation: Inclusion of ferrostatin-1 (Fer-1), an established ferroptosis inhibitor, to confirm the involvement of ferroptotic mechanisms.
Core Findings and Why They Matter
The study reports several converging lines of evidence linking PFOS exposure to ferroptosis and ER stress in renal cells:- PFOS treatment significantly increased intracellular MDA and iron levels, while decreasing GSH and GPX-4, indicating robust activation of ferroptosis.
- Markers of ER stress—including GRP78, ATF6, IRE1, and PERK—were all upregulated in response to PFOS, establishing a clear connection between PFOS toxicity and the endoplasmic reticulum stress pathway.
- KIM-1 expression was elevated, substantiating the occurrence of tubular injury.
- Use of Fer-1 partially rescued cell viability, further supporting the central role of ferroptosis in PFOS-induced injury.
Comparison with Existing Internal Articles
Several internal resources expand on the utility of chemical chaperones and ER stress modulators in related research contexts. For example, this article provides a detailed overview of PFOS-induced ferroptosis and ER stress in HK-2 cells, directly corroborating the mechanisms elucidated in the reference study. Meanwhile, resources such as 4-Phenylbutyric Acid (4-PBA): Gold-Standard Chemical Chaperone and Advanced Strategies for Targeting ER Stress discuss the validated role of 4-Phenylbutyric acid (4-PBA) in modulating ER stress responses in cellular models, including those involving apoptosis and autophagy. These articles collectively underline the translational value of targeting ER stress and support the application of chemical chaperones as research tools for dissecting stress response pathways in models of environmental toxicity.Limitations and Transferability
Despite robust molecular data, this study is limited by its reliance on a single cell line and acute PFOS exposure conditions. The concentrations used may not directly reflect chronic environmental exposure levels seen in human populations. Additionally, while the study confirms the involvement of ferroptosis and ER stress, it does not delineate the temporal sequence or possible crosstalk between these two pathways. Transferability to in vivo systems or to other renal cell types should be approached with caution, and further research is needed to validate these mechanisms in animal models or primary human tissues.Protocol Parameters
- PFOS exposure: HK-2 cells were treated with 200 μM PFOS for up to 24 hours to induce ferroptosis and ER stress responses.
- Ferroptosis inhibition: 1 μM ferrostatin-1 (Fer-1) co-treatment was used to assess the contribution of ferroptotic cell death.
- Markers and endpoints: MDA, GSH, intracellular iron, GPX-4, KIM-1, and ER stress proteins (GRP78, ATF6, IRE1, PERK) were quantified by established colorimetric and immunoblotting assays.
- ER stress modulation (workflow suggestion): For studies aiming to modulate ER stress, pre-treatment with a chemical chaperone such as 4-Phenylbutyric acid (concentration range: 0.5–5 mM, pre-incubation for 2–24 hours depending on cell line sensitivity) is recommended to evaluate the protective effect on ER stress markers and cell viability.